Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology

被引:88
作者
Mazurier, C [1 ]
Goudemand, J
Hilbert, L
Caron, C
Fressinaud, E
Meyer, D
机构
[1] LAb Francais Fractionnement & Biotechnol, Analyt Dept, Lille, France
[2] Univ Lille 2, Dept Haematol, F-59800 Lille, France
[3] Ctr Hosp Reg & Univ Lille, Haematol Lab, Lille, France
[4] Hop Bicetre, INSERM, U143, Le Kremlin Bicetre, France
关键词
type 2N von Willebrand disease; factor VIII binding; von Willebrand factor;
D O I
10.1053/beha.2001.0138
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2N von Willebrand disease encompasses all patients with factor VIII deficiency caused by a markedly decreased affinity of von Willebrand factor for factor VIII. It is recessively inherited and clinically similar to mild haemophilia. The differential biological diagnosis is of major importance for providing the optimal treatment and relevant genetic counselling. This accurate diagnosis is based on an evaluation of the factor V111-binding capacity of plasma von Willebrand factor. Furthermore, molecular biology techniques allow the identification of missense mutations in the von Willebrand factor gene. All of these induce the substitution of amino acid residues located in the N terminal part of the mature von Willebrand factor molecule, which contains the factor VIII binding site. Most of them induce a classical type 2N von Willebrand disease phenotype with factor VIII deficiency but a normal level and multimeric pattern of von Willebrand factor.
引用
收藏
页码:337 / 347
页数:11
相关论文
共 47 条
[1]   Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor [J].
Allen, S ;
Abuzenadah, AM ;
Blagg, JL ;
Hinks, J ;
Nesbitt, IM ;
Goodeve, AC ;
Gursel, T ;
Ingerslev, J ;
Peake, IR ;
Daly, ME .
BLOOD, 2000, 95 (06) :2000-2007
[2]  
Bowen DJ, 1998, THROMB HAEMOSTASIS, V80, P32
[3]  
CACHERIS PM, 1991, J BIOL CHEM, V266, P13499
[4]  
Casonato A, 1998, BRIT J HAEMATOL, V103, P39
[5]   RECESSIVE INHERITANCE OF VONWILLEBRANDS DISEASE TYPE-I [J].
EIKENBOOM, JCJ ;
REITSMA, PH ;
PEERLINCK, KMJ ;
BRIET, E .
LANCET, 1993, 341 (8851) :982-986
[6]  
FOSTER PA, 1987, J BIOL CHEM, V262, P8443
[7]   IDENTIFICATION OF 2 POINT MUTATIONS IN THE VONWILLEBRAND-FACTOR GENE OF 3 FAMILIES WITH THE NORMANDY VARIANT OF VONWILLEBRAND DISEASE [J].
GAUCHER, C ;
MERCIER, B ;
JORIEUX, S ;
OUFKIR, D ;
MAZURIER, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1991, 78 (04) :506-514
[8]  
GAUCHER C, 1991, BLOOD, V77, P1937
[9]   Patient with type 2N von Willebrand disease is heterozygous for a new mutation: Gly22Glu. Demonstration of a defective expression of the second allele by the use of monoclonal antibodies [J].
Gu, J ;
Jorieux, S ;
Lavergne, JM ;
Ruan, C ;
Mazurier, C ;
Meyer, D .
BLOOD, 1997, 89 (09) :3263-3269
[10]  
Hilbert L, 1999, THROMB HAEMOSTASIS, P282